✦ LIBER ✦

Radiochemotherapy with amifostine cytoprotection for head and neck cancer

✍ Scribed by J. Büntzel; Julius Schuth; Klaus Küttner; Michael Glatzel

Book ID: 106174929
Publisher: Springer-Verlag
Year: 1998
Tongue: English
Weight: 145 KB
Volume: 6
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s005200050150

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Planned Neck Dissection after Concomitan

Planned Neck Dissection after Concomitant Radiochemotherapy for Advanced Head and Neck Cancer

✍ Frank, Douglas K. (author);Hu, Kenneth S. (author);Culliney, Bruce E. (author);P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Planned Neck Dissection after Concomitan

Planned Neck Dissection after Concomitant Radiochemotherapy for Advanced Head and Neck Cancer

✍ Frank, Douglas K. (author);Hu, Kenneth S. (author);Culliney, Bruce E. (author);P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Neck dissection after radiochemotherapy

Neck dissection after radiochemotherapy in patients with locoregionally advanced head and neck cancer

✍ Mario López Rodríguez; Laura Cerezo Padellano; Margarita Martín Martín; Felipe C 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 219 KB

Definitive radiochemotherapy of advanced

Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel

✍ Robert Semrau; Susanne Temming; Simon Florian Preuss; Jens Peter Klußmann; Orlan 📂 Article 📅 2011 🏛 Springer 🌐 German ⚖ 243 KB

Daily Amifostine Given Concomitantly to

Daily Amifostine Given Concomitantly to Chemoradiation in Head and Neck Cancer

✍ Daniela Trog; Priska Bank; Thomas G. Wendt; Sven Koscielny; Eggert Beleites 📂 Article 📅 1999 🏛 Springer 🌐 German ⚖ 151 KB

Polaprezinc prevents oral mucositis asso

Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer

✍ Tomoko Watanabe; Masashi Ishihara; Katsuhiko Matsuura; Keisuke Mizuta; Yoshinori 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 192 KB 👁 1 views

## Abstract Oral mucositis is frequent but serious adverse event associated with radiotherapy or radiochemotherapy in head and neck cancer severely impairs health‐related quality of life, leading to poor prognosis due to discontinuation of the therapy. Although a number of compounds have been teste